BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 17464150)

  • 1. Liver support systems.
    Santoro A; Mancini E; Ferramosca E; Faenza S
    Contrib Nephrol; 2007; 156():396-404. PubMed ID: 17464150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver support systems today].
    Rikker C
    Orv Hetil; 2009 Dec; 150(51):2299-307. PubMed ID: 19995693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearing of toxic substances: are there differences between the available liver support devices?
    Krisper P; Stadlbauer V; Stauber RE
    Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver support technology--an update.
    Rozga J
    Xenotransplantation; 2006 Sep; 13(5):380-9. PubMed ID: 16925661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of the latest extracorporal elimination procedure (Prometheus treatment) in acute liver failure caused by intoxication].
    Bakos A; Rikker C; Tóvárosi S; Kárteszi M
    Orv Hetil; 2007 Oct; 148(42):1981-8. PubMed ID: 17932004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.
    Kobashi-Margáin RA; Gavilanes-Espinar JG; Gutiérrez-Grobe Y; Gutiérrez-Jiménez AA; Chávez-Tapia N; Ponciano-Rodríguez G; Uribe M; Méndez Sánchez N
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S70-6. PubMed ID: 22228886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
    Krisper P; Stauber RE
    Nat Clin Pract Nephrol; 2007 May; 3(5):267-76. PubMed ID: 17457360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of methods to remove protein-bound substances in liver failure.
    Hughes RD
    Int J Artif Organs; 2002 Oct; 25(10):911-7. PubMed ID: 12456030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioartificial liver: current status.
    Pless G; Sauer IM
    Transplant Proc; 2005 Nov; 37(9):3893-5. PubMed ID: 16386576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can liver toxins be removed? Filtration and adsorption with the Prometheus system.
    Vienken J; Christmann H
    Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure.
    Saliba F
    Crit Care; 2006 Feb; 10(1):118. PubMed ID: 16542471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
    Donati G; La Manna G; Cianciolo G; Grandinetti V; Carretta E; Cappuccilli M; Panicali L; Iorio M; Piscaglia F; Bolondi L; Colì L; Stefoni S
    Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters].
    Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GF; Schmidt R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):199-206. PubMed ID: 15832238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal liver support: waiting for the deciding vote.
    Adham M
    ASAIO J; 2003; 49(6):621-32. PubMed ID: 14655724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure.
    Di Campli C; Zileri Dal Verme L; Andrisani MC; Armuzzi A; Candelli M; Gaspari R; Gasbarrini A
    Curr Med Chem; 2003 Feb; 10(4):341-8. PubMed ID: 12570706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.